Results 71 to 80 of about 27,667 (182)

Validation of the geriatric anxiety inventory in a duloxetine clinical trial for elderly adults with generalized anxiety disorder [PDF]

open access: yes, 2015
Background: The Generalized Anxiety Inventory (GAI) has been developed for use in the assessment of anxiety symptoms in older adults (≥ 65 years), but previous validation work has not examined the psychometric qualities of the instrument in relation to ...
Ball, Susan G.   +2 more
core   +1 more source

Duloxetine hydrochloride induced syndrome of inappropriate antidiuretic hormone secretion in depression treatment: a case report

open access: yesSichuan jingshen weisheng
Duloxetine hydrochloride,a serotonin-norepinephrine reuptake inhibitor (SNRIs), is a commonly used antidepressants. Its mechanism of action involves increasing synaptic monoamine neurotransmitters concentration, leading to antidepressant effects.
Yang Shuting, Fan Ajiao
doaj   +1 more source

Effectiveness of Duloxetine versus Other Therapeutic Modalities in Patients with Diabetic Neuropathic Pain: A Systematic Review and Meta-Analysis

open access: yesPharmaceuticals
Objectives: Diabetic peripheral neuropathy (DPN) is a chronic complication of diabetes mellitus (DM) with symptoms like intense pain and impaired quality of life. This condition has no treatment; instead, the pain is managed with various antidepressants,
Juan José Valenzuela-Fuenzalida   +9 more
doaj   +1 more source

Interventions for post-stroke fatigue [PDF]

open access: yes, 2015
BACKGROUND: Post-stroke fatigue (PSF) is a common and distressing problem after stroke. The best ways to prevent or treat PSF are uncertain. Several different interventions can be argued to have a rational basis.
Chun, Ho-Yan Y.   +10 more
core   +2 more sources

Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder

open access: yesNeuropsychiatric Disease and Treatment, 2013
Kei Nagao,1,2 Taro Kishi,1 Masatsugu Moriwaki,1 Kiyoshi Fujita,3,4 Shigeki Hirano,5 Yoshio Yamanouchi,1 Toshihiko Funahashi,2 Nakao Iwata1 1Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, Japan; 2Department of ...
Nagao K   +7 more
doaj  

Effects of MDMA alone and after pretreatment with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex [PDF]

open access: yes, 2018
Rationale: Pupillometry can be used to characterize autonomic drug effects. Objective: This study was conducted to determine the autonomic effects of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy), administered alone and after pretreatment with ...
Hysek, Cédric, Liechti, Matthias
core  

The effect of duloxetine on stress urinary incontinence

open access: yesHealth Science Reports
Background and Aims This study aims to evaluate the effect of duloxetine on stress urinary incontinence (SUI) episode frequency (IEF) per week IEF. Methods In this clinical trial, 100 women aged 20−80 years with urinary incontinence were assessed based ...
Nahid Lorzadeh, Moghadaseh Jahanshahi
doaj   +1 more source

MDMA enhances "mind reading” of positive emotions and impairs "mind reading” of negative emotions [PDF]

open access: yes, 2018
Rationale: 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) increases sociability. The prosocial effects of MDMA may result from the release of the "social hormone” oxytocin and associated alterations in the processing of socioemotional stimuli ...
Domes, Gregor   +2 more
core  

Clinical meaningfulness of duloxetine's effect in Chinese patients with chronic pain due to osteoarthritis: post hoc analyses of a phase 3 randomized trial

open access: yesOpen Access Rheumatology: Research and Reviews, 2019
Li Yue,1 Sheng Luo,2 Yiwen Wang,1 Chia-Ning Wang,1 Héctor José Dueñas,3 Vladimir Skljarevski4 1Lilly Suzhou Pharmaceutical Co. Ltd. Shanghai Branch, Shanghai, PR China; 2Department of Pain Treatment, Beijing Hospital of the Ministry ...
Yue L   +5 more
doaj  

Home - About - Disclaimer - Privacy